# Posts by BiotechNews.io (page 2 of 5)

110 posts.

- [NKGen Biotech Reports Long-Term Clinical Observations with Investigational Alzheimer’s Treatment Troculeucel at CTAD 2026](https://biotechnews.io/news/nkgen-biotech-reports-long-term-clinical-observations-with-investigational-alzheimers-trea.md) (2026-11-16)
- [PRISM MarketView Highlights Seven Small-Cap Lung Cancer Developers for Lung Cancer Awareness Month](https://biotechnews.io/news/prism-marketview-highlights-seven-small-cap-lung-cancer-developers-for-lung-cancer-awarene.md) (2026-11-16)
- [Non-Animal Alternative Testing - Global Strategic Business Report 2026: Capitalize on 13.3% CAGR and $4.7B by 2032 as Abbott, Charles River, Emulate, Evotec, and Bio-Rad Reshape Testing](https://biotechnews.io/news/non-animal-alternative-testing-global-strategic-business-report-2026-capitalize-on-13-3-ca.md) (2026-11-16)
- [Veterinary Molecular Diagnostics Market Size, Share, and Trends - Global Forecast to 2036 | Point-of-Care PCR, Sequencing, and Genomic Testing Drive 9.2% CAGR Toward USD 2.13 Billion](https://biotechnews.io/news/veterinary-molecular-diagnostics-market-size-share-and-trends-global-forecast-to-2036-poin.md) (2026-11-16)
- [Global Human Liver Model Market Report 2026: Size, Share, Trends, and Forecast to 2030 | 3D Models and Organ-on-a-Chip Propel 15.03% CAGR and US$3.81 Billion Opportunity](https://biotechnews.io/news/global-human-liver-model-market-report-2026-size-share-trends-and-forecast-to-2030-3d-mode.md) (2026-11-16)
- [Mice Model - Global Strategic Business Report 2026: Capitalize on a $3.4 Billion Market by 2032 as Charles River, LabCorp, Taconic Biosciences and The Jackson Laboratory Accelerate CRISPR](https://biotechnews.io/news/mice-model-global-strategic-business-report-2026-capitalize-on-a-3-4-billion-market-by-203.md) (2026-11-16)
- [Microarray Analysis Market Size, Share, and Trends - Global Forecast 2026-2036 | Population Genotyping, Clinical Cytogenetics, and Asia-Pacific Growth Create a USD 2.58 Billion Opportunity](https://biotechnews.io/news/microarray-analysis-market-size-share-and-trends-global-forecast-2026-2036-population-geno.md) (2026-11-16)
- [Humanized Mouse and Rat Model - Global Strategic Business Report 2026: Capitalize on 9.7% CAGR to $231.6M by 2032 as Charles River, Biocytogen, Taconic and The Jackson Laboratory reshape drug R&D](https://biotechnews.io/news/humanized-mouse-and-rat-model-global-strategic-business-report-2026-capitalize-on-9-7-cagr.md) (2026-11-16)
- [In Vivo Contract Research Organization (CRO) Market - Global Forecast 2026-2032 | AI, Advanced Models, and Drug Development Outsourcing Drive 8.42% CAGR Toward USD 9.45 Billion](https://biotechnews.io/news/in-vivo-contract-research-organization-cro-market-global-forecast-2026-2032-ai-advanced-mo.md) (2026-11-16)
- [Global Full-Spectrum Fluorescence in Vivo Imaging System Market - Forecast 2026-2032 | AI-Enabled Analysis and Preclinical Research Demand Drive 8.02% CAGR Toward USD 4.14 Billion](https://biotechnews.io/news/global-full-spectrum-fluorescence-in-vivo-imaging-system-market-forecast-2026-2032-ai-enab.md) (2026-11-16)
- [Global Nuclear Receptor Screening Services Market Size, Share, and Trends - Forecast 2026-2032 | AI and Automation Fuel 11.74% CAGR, Creating a USD 2.22 Billion Opportunity](https://biotechnews.io/news/global-nuclear-receptor-screening-services-market-size-share-and-trends-forecast-2026-2032.md) (2026-11-16)
- [Rapid Micro Biosystems Reports Third Quarter 2026 Financial Results](https://biotechnews.io/news/rapid-micro-biosystems-reports-third-quarter-2026-financial-results.md) (2026-11-16)
- [Rapid Micro Biosystems Signs Definitive Agreement to be Acquired by Merck KGaA, Darmstadt, Germany](https://biotechnews.io/news/rapid-micro-biosystems-signs-definitive-agreement-to-be-acquired-by-merck-kgaa-darmstadt-g.md) (2026-11-16)
- [MindBio Achieves Significant Product Development Milestone with up to 83% Accuracy in Intoxication Detection Using Voice Analytics and AI; Announces Private Placement](https://biotechnews.io/news/mindbio-achieves-significant-product-development-milestone-with-up-to-83-accuracy-in-intox.md) (2026-11-16)
- [SCIENTURE Reports Q3 2026 Results with Approximately 265% Sequential Revenue Growth Driven by the Commercial Launch of REZENOPY™](https://biotechnews.io/news/scienture-reports-q3-2026-results-with-approximately-265-sequential-revenue-growth-driven.md) (2026-11-16)
- [AI-Driven Mobile Genomics Poised for Disruption as Edge Computing and Portable Sequencing Converge](https://biotechnews.io/news/ai-driven-mobile-genomics-poised-for-disruption-as-edge-computing-and-portable-sequencing.md) (2026-11-16)
- [Fareon Presents Research Linking Microtesla Magnetic Therapy to Improvements in Cognitive Function and Biological Markers of Brain Health at Society for Neuroscience (SfN) Annual Meeting](https://biotechnews.io/news/fareon-presents-research-linking-microtesla-magnetic-therapy-to-improvements-in-cognitive.md) (2026-11-16)
- [NeOnc CEO Amir Heshmatpour’s 2026 Open-Market Share Purchases Exceed $1.5 Million](https://biotechnews.io/news/neonc-ceo-amir-heshmatpours-2026-open-market-share-purchases-exceed-1-5-million.md) (2026-11-16)
- [VivoSim Labs to Showcase Breakthrough Multiparametric NAMkind™ Liver and Intestine Data at the 2026 American College of Toxicology (ACT) Annual Meeting](https://biotechnews.io/news/vivosim-labs-to-showcase-breakthrough-multiparametric-namkind-liver-and-intestine-data-at.md) (2026-11-16)
- [Iambic Provides Business Updates and Third Quarter 2026 Financial Results](https://biotechnews.io/news/iambic-provides-business-updates-and-third-quarter-2026-financial-results.md) (2026-11-16)
- [Akebia Enters into Term Loan Facility with Symbiotic Capital Worth Up to $140 Million](https://biotechnews.io/news/akebia-enters-into-term-loan-facility-with-symbiotic-capital-worth-up-to-140-million.md) (2026-11-16)
- [Medicus Pharma Announces Closing of $4.25 Million CEO-Led Equity Financings and $10.5 Million Debt Exchange](https://biotechnews.io/news/medicus-pharma-announces-closing-of-4-25-million-ceo-led-equity-financings-and-10-5-millio.md) (2026-11-16)
- [Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update](https://biotechnews.io/news/instil-bio-reports-third-quarter-2026-financial-results-and-provides-corporate-update.md) (2026-11-16)
- [Medicenna Reports More than Doubling of Median Overall Survival in Glioblastoma Patients With Unresectable Recurrent IDH-WT Tumors Following One Treatment with Bizaxofusp Versus a Matched External Control at SNO 2026](https://biotechnews.io/news/medicenna-reports-more-than-doubling-of-median-overall-survival-in-glioblastoma-patients-w.md) (2026-11-16)

[Newer](https://biotechnews.io/author/biotechnews-io.md) · [Older](https://biotechnews.io/author/biotechnews-io/page/3.md)